Results 1 to 10 of about 17,743 (275)

Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members [PDF]

Journal of Translational Medicine, 2018
Germline mutations in the BRCA-1 associated tumor protein 1 (BAP1) increase susceptibility to mesothelioma and other cancers. We describe a patient with a family history of peritoneal mesothelioma, who developed malignant peritoneal mesothelioma at age ...
Muaiad Kittaneh, Charles Berkelhammer
doaj   +2 more sources

Hyperleukocytosis, leukemoid reaction caused by malignant peritoneal mesothelioma: a case report and review of literature [PDF]

Frontiers in Oncology
Paraneoplastic leukemoid reaction (PLR)-induced hyperleukocytosis remains a critical diagnostic challenge. Malignant peritoneal mesothelioma, known for its nonspecific clinical presentation, often evades early detection. We report a 75-year-old male with
Kaibo Zhu, Dan Zhou, Kang Liu, Lingzhen Wu, Lingzhen Wu, Juan Jin, Zimian Luo   +6 more
doaj   +2 more sources

Case report: A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence [PDF]

SAGE Open Medical Case Reports
Malignant peritoneal mesothelioma is an exceedingly rare malignant tumor. Herein, we present a case of malignant peritoneal mesothelioma in a 59-year-old Chinese female patient who was stable after treatment for multiple relapses.
Ying Li, Jintao Yang, Bei Zheng, Na Yan, Wenjuan Yang, Xinling Xie, Guoshu Xu, Meiling Zhang   +7 more
doaj   +2 more sources

Peritoneal mesothelioma and asbestos exposure: a population-based case-control study in Italy, 2000-2021. [PDF]

Occup Environ Med
Consonni D, Migliore E, Gangemi M, Cavone D, Vimercati L, Piro S, Giovannetti L, Zabeo V, Comiati V, Curti S, Mattioli S, Landi MT, Gioscia C, Eccher S, Murano S, D'Agostin F, Genova C, Perduri R, Grappasonni I, Stracci F, Cozzi I, Staniscia T, Calista F, Angelillo IF, Galasso R, Tallarigo F, Cascone G, Melis M, Peters S, Kromhout H, Binazzi A, Marinaccio A, Mensi C, ReNaM Working Group.   +33 more
europepmc   +3 more sources

Long Road to Identifying Peritoneal Mesothelioma: An Elusive Diagnosis. [PDF]

Cureus
Konduru TS, Gourisaria G, Ozen G, Karunakaran Thozhuthumparambil P.   +3 more
europepmc   +3 more sources

Peritoneal mesothelioma [PDF]

Translational Lung Cancer Research, 2020
Malignant peritoneal mesothelioma (MPM) is a rare and lethal disease of the peritoneal lining, with high variability in biologic aggressiveness. Morbidity and mortality of the disease are related to progressive locoregional effects within the abdominal cavity, such as distention, pain, early satiety, and decreased oral intake that can ultimately lead ...
Greenbaum, Alissa, Alexander, H. Richard
  +6 more sources

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making

Insights into Imaging, 2021
The peritoneal cavity is the second commonest site of mesothelioma after the pleural cavity. There are five histological types of peritoneal mesothelioma with variable symptomatology, clinical presentation and prognosis.
Anuradha Chandramohan, Nehal Shah, Andrew Thrower, Norman John Carr, Rohin Mittal, Faheez Mohamed, Brendan Moran   +6 more
doaj   +1 more source

Diffuse malignant peritoneal mesothelioma presenting as small bowel obstruction

Radiology Case Reports, 2023
Mesotheliomas are aggressive malignant tumors which can occur most commonly in the pleural space, however can occur in the peritoneum in those with an extensive history of asbestos exposure.
Ariana R. Tagliaferri, MD, Gabriel Melki, MD, Abraam Rezkalla, MD, Walid Baddoura, MD   +3 more
doaj   +1 more source

Pediatric patient with peritoneal mesothelioma harboring ALK rearrangement

Current Problems in Cancer: Case Reports, 2021
Malignant mesothelioma is a rare disease that typically occurs in older patients with prolonged exposure to asbestos. The majority of mesothelioma occurs in the pleura.
Reema A Patel, MD, Miranda Lin, BS, Megan M Harper, MS, MD, Sandra J Beck, MD, Charles S Dietrich, MD, Jill M Kolesar, PhD, MS, Susanne M Arnold, MD, John Hahn, MD, Prakash K Pandalai, MD, Shadi A Qasem, MD, Joseph Kim, MD   +10 more
doaj   +1 more source

Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. [PDF]

PLoS ONE, 2015
Peritoneal mesothelioma is a rare and sometimes lethal malignancy that presents a clinical challenge for both diagnosis and management. Recent studies have led to a better understanding of the molecular biology of peritoneal mesothelioma.
Brandon S Sheffield, Anna V Tinker, Yaoqing Shen, Harry Hwang, Hector H Li-Chang, Erin Pleasance, Carolyn Ch'ng, Amy Lum, Julie Lorette, Yarrow J McConnell, Sophie Sun, Steven J M Jones, Allen M Gown, David G Huntsman, David F Schaeffer, Andrew Churg, Stephen Yip, Janessa Laskin, Marco A Marra   +18 more
doaj   +1 more source